全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 177952-39-5 | 2,4-Bis(trifluoromethyl)phenylacetic acid | C10H6F6O2 |
| 177954-78-8 | 3-Amino-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one | C17H14F3N3O |
| 177966-52-8 | 5-Bromo-4-chloro-1H-indol-3-yl 4-O-beta-D-glucopyranosyl-beta-D-glucopyranoside | C20H25BrClNO11 |
| 177966-58-4 | Fmoc-3,4-dichloro-D-phenylalanine;Fmoc-D-Phe(3,4-Cl2)-OH; Fmoc-D-3,4-Dichlorophe; Fmoc-D-Phe(3,4-DiCl)-OH; Fluorenylmethoxycarbonyl-D-3,4-dichlorophenylalanine | C24H19Cl2NO4 |
| 177966-59-5 | Fmoc-3,4-dichloro-L-phenylalanine;Fmoc-Phe(3,4-Cl2)-OH; Fmoc-L-3,4-Dichlorophe; Fluorenylmethoxycarbonyl-L-3,4-dichlorophenylalanine | C24H19Cl2NO4 |
| 177966-60-8 | Fmoc-L-3-(3-Benzothienyl)alanine | C26H21NO4S |
| 177966-61-9 | (alphaR)-alpha-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]benzo[b]thiophene-3-propanoic acid | C26H21NO4S |
| 177966-63-1 | Fmoc-4-nitro-D-phenylalanine;Fmoc-p-nitro-D-Phe-OH; Fmoc-D-Phe(4-NO2)-OH; Fmoc-D-4-Nitrophe; Fluorenylmethoxycarbonyl-D-4-nitrophenylalanine | C24H20N2O6 |
| 177966-64-2 | Fmoc-4-fluoro-D-phenylalanine;(R)-N-Fmoc-4-Fluorophenylalanine; Fmoc-D-4-Fluorophe; Fmoc-p-fluoro-D-Phe-OH; Fmoc-D-Phe(4-F)-OH; Fluorenylmethoxycarbonyl-D-4-fluorophenylalanine | C24H20FNO4 |
| 177985-32-9 | 2-Chloro-4-fluorophenylacetic acid | C8H6ClFO2 |
| 177985-33-0 | 2-Chloro-5-fluorophenylacetic acid | C8H6ClFO2 |
| 177985-34-1 | 5-Bromo-2-chlorobenzeneacetic acid;(5-Bromo-2-chlorophenyl)acetic acid; 2-Chloro-5-bromophenylacetic acid | C8H6BrClO2 |
| 177995-38-9 | 3-Amino-6-fluoro-1,2-benzisoxazole | C7H5FN2O |
| 177995-39-0 | 6-Bromobenzo[d]isoxazol-3-amine | C7H5BrN2O |
| 177995-40-3 | 4-Methoxy-1,2-benzisoxazol-3-amine;3-Amino-4-methoxybenzo[d]isoxazole | C8H8N2O2 |
| 178039-84-4 | 6-Amino-2,2'-bipyridine | C10H9N3 |
| 178064-13-6 | (-)-Bacopasaponin C;Bacopasaponin C; (1S,2R,4aR,6aS,6bR,8aR,10S,12aR,12bR,14aR,14bS)-Hexadecahydro-1-hydroxy-1,6b,9,9,12a-pentamethyl-2-(2-methyl-1-propen-1-yl)-4a,6a-methano-1H,6H-phenanthro[2,1-d]pyrano[2,3-b]pyran-10-yl O-alpha-L-arabinofuranosyl-(1-2)-O-[beta-D-glucopyranosyl-(1-3)]-alpha-L-arabinopyranoside | C46H74O17 |
| 178101-88-7 | L-Ascorbic acid-1-<sup>13</sup>C;Vitamin C-1-<sup>13</sup>C;(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-(513C)2H-furan-5-one | C513CH8O6 |
| 178167-75-4 | Gamma-CEHC;3-(6-hydroxy-2,7,8-trimethyl-3,4-dihydrochromen-2-yl)propanoic acid | C15H20O4 |
| 178172-26-4 | (S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester;(S)-1-tert-Butyl 2-ethyl 2,3-dihydro-1H-pyrrole-1,2-dicarboxylate; Ethyl N-Boc-L-proline-4-ene | C12H19NO4 |
| 178233-72-2 | 4-Isopropyl-4'-methyldiphenyliodonium tetrakis(pentafluorophenyl)borate | C16H18I.C24BF20 |
| 178261-41-1 | 1-(Methylsulfonyl)spiro[indoline-3,4'-piperidine] | C13H18N2O2S |
| 178262-31-2 | 7-Isoquinolinecarboxylic acid methyl ester | C11H9NO2 |
| 178305-99-2 | 2-Fluoro-4-biphenylylboronic acid | C12BFH10O2 |
| 178306-47-3 | 2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid methyl ester | C17H18O4 |
| 178306-51-9 | 2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid;alpha-Hydroxy-beta-methoxy-beta-phenylbenzenepropanoic acid | C16H16O4 |
| 178306-52-0 | (S)-2-Hydroxy-3-methoxy-3,3-diphenylpropionic acid | C16H16O4 |
| 178307-42-1 | Revaprazan hydrochloride;5,6-Dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinolin-2-yl)pyrimidine hydrochloride | C22H23FN4.HCl |
| 178308-61-7 | 1,4-Dichloro-6-phthalazinecarbonitrile | C9H3Cl2N3 |
| 178310-99-1 | (4,4-Difluorocyclohexyl)methyl 4-methylbenzenesulfonate | C14H18F2O3S |
| 178311-48-3 | 1-(tert-Butoxycarbonyl)-3-(1-piperazinyl)azetidine;3-(Piperazin-1-yl)azetidine-1-carboxylic acid tert-butyl ester; tert-Butyl 3-(1-piperazinyl)-1-azetidinecarboxylate | C12H23N3O2 |
| 178312-47-5 | Ethyl 4,4-difluorocyclohexanecarboxylate | C9H14F2O2 |
| 178312-48-6 | 4,4-Difluorocyclohexanemethanol;(4,4-Difluorocyclohexyl)methanol | C7H12F2O |
| 178312-62-4 | Homomorpholine hydrochloride | C5H11NO.HCl |
| 178372-19-5 | 2-(3-(Pyridin-2-yl)pyrrolidin-3-yl)ethanol | C11H16N2O |
| 178396-31-1 | 6-Bromo-8-methylquinoline | C10H8BrN |
| 178420-75-2 | N-[3-[4-Amino-7-(2-deoxy-beta-D-erythro-pentofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-2-propyn-1-yl]-2,2,2-trifluoroacetamide;7-TFA-ap-7-Deaza-dA | C16H16F3N5O4 |
| 178424-17-4 | 1-tert-butyl 4-ethyl 3-hydroxy-1H-pyrazole-1,4-dicarboxylate | C11H16N2O5 |
| 178432-25-2 | 2-(N,N-Dimethylsulphamoyl)phenylboronic acid;2-(N,N-Dimethylsulphamoyl)benzeneboronic acid | C8H12BNO4S |
| 178432-50-3 | (R)-3,4-Dihydro-7-hydroxy-2,3(1H)-isoquinolinedicarboxylic acid 2-(9H-fluoren-9-ylmethyl) ester | C25H21NO5 |
| 178436-06-1 | Ceramide np;(Z)-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]octadec-9-enamide | C36H71NO4 |
| 178439-26-4 | 1,1'-Difluoro-2,2'-bipyridinium bis(tetrafluoroborate) | C10H8B2F10N2 |
| 178454-81-4 | (3aR,4R,5R,6aS)-5-(Benzoyloxy)-4-[(1E)-4-(3-chlorophenoxy)-3-oxo-1-buten-1-yl]hexahydro-2H-cyclopenta[b]furan-2-one | C24H21ClO6 |
| 178455-04-4 | (3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-alpha-[(1R)-1-methylethyl]-4,6-methano-1,3,2-benzodioxaborole-2-methanamine hydrochloride | C14H26BNO2.HCl |
| 178488-37-4 | 5-Methylimidazo[1,2-a]pyridine-3-carbaldehyde | C9H8N2O |
| 178554-19-3 | 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide | C27H31N7O2 |
| 178556-79-1 | 5-(4-(Trifluoromethyl)phenyl)-4H-1,2,4-triazol-3-amine | C9H7F3N4 |
| 178557-21-6 | 8-Bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b']difuran-4-ethanamine hydrochloride | C12H14BrNO2.HCl |
| 178603-78-6 | Caspase-1 Inhibitor II;Ac-YVAD-CMK; N-Acetyl-L-tyrosyl-L-valyl-N-[(1S)-1-(carboxymethyl)-3-chloro-2-oxopropyl]-L-alaninamide | C24H33ClN4O8 |
| 178606-66-1 | 4-[[[(4-Fluorophenyl)amino]carbonyl]amino]benzenesulfonamide;NSC 213841; U 104 | C13H12FN3O3S |